ACTIVE

FARMA - BOVAN

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

26,8 k €

-34.7% YoY

Gross margin

52,4 k €

-15.5% YoY

Equity

178,5 k €

+17.6% YoY

Workforce

0,0 ETP

What does FARMA - BOVAN do?

FARMA - BOVAN is a Public limited company incorporated in 1986. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Sint-Niklaas.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0429.239.351

Incorporation

27/06/1986

Legal form

Public limited company

Registered office

Vijfstraten 209
9100 Sint-Niklaas · FlandreSee on map

Contributed capital

61 973,38 €

Latest accounts

31/12/2024

Average workforce

0,0 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2024		2023		2022		2021		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	52,4 k €	-15.5%	62 k €	+2421%	2,5 k €	-97.9%	117,1 k €	+27.3%	92 k €	-19.1%	113,7 k €	-29.1%	160,5 k €	+6.2%	151,1 k €	-16.7%	181,5 k €	+42.8%	127,2 k €	-38.0%	205,1 k €	+38.7%	147,8 k €	-25.7%	198,9 k €	+27.0%	156,5 k €	+61.9%	96,7 k €	+26.6%	76,4 k €	-34.2%	116,1 k €
EBITDA	48,9 k €	-16.7%	58,7 k €	+12412%	-477 €	-101%	69,1 k €	+86.0%	37,1 k €	+58.2%	23,5 k €	-38.0%	37,9 k €	+66.2%	22,8 k €	-4.8%	23,9 k €	+4367%	-560,5 €	-101%	47,3 k €	+49.3%	31,7 k €	-14.0%	36,8 k €	+717%	-6 k €	-774%	886,4 €	+103%	-27 k €	-421%	8,4 k €
Operating result	30,7 k €	-24.0%	40,4 k €	+306%	-19,6 k €	-139%	50 k €	+190%	17,2 k €	+588%	2,5 k €	-85.2%	16,9 k €	+771%	1,9 k €	-34.0%	2,9 k €	+114%	-21,1 k €	-182%	25,7 k €	+187%	8,9 k €	-32.5%	13,2 k €	+137%	-36 k €	-1333%	-2,5 k €	+92.0%	-31,4 k €	-2717%	1,2 k €
Net result	26,8 k €	-34.7%	41 k €	+310%	-19,5 k €	-149%	40,2 k €	+116%	18,6 k €	+1903%	929,8 €	-94.0%	15,5 k €	+1609%	906,8 €	+114%	-6,6 k €	+78.1%	-30,2 k €	-446%	8,7 k €	+215%	-7,6 k €	-700%	-943,7 €	+97.6%	-39,5 k €	-385%	13,8 k €	+429%	-4,2 k €	-124%	17,8 k €
Balance sheet
Equity	178,5 k €	+17.6%	151,7 k €	+37.0%	110,8 k €	-15.0%	130,3 k €	+84.2%	70,7 k €	+35.7%	52,1 k €	+1.8%	51,2 k €	+43.5%	35,7 k €	+2.6%	34,8 k €	-15.9%	41,4 k €	-42.2%	71,5 k €	+13.9%	62,8 k €	-10.7%	70,4 k €	-1.3%	71,3 k €	-35.6%	110,8 k €	-81.4%	597 k €	-0.7%	601,2 k €
Total assets	557,5 k €	+1.0%	552,2 k €	+4.3%	529,5 k €	-14.4%	618,7 k €	-11.2%	697 k €	+12.8%	617,7 k €	-14.9%	725,7 k €	+5.6%	687,1 k €	-11.2%	774 k €	-4.5%	810,5 k €	+0.2%	809,2 k €	-2.4%	829,5 k €	+0.8%	822,8 k €	+5.5%	779,6 k €	+71.6%	454,3 k €	-50.4%	916 k €	-15.5%	1,1 M €
Cash	14,7 k €	+311%	3,6 k €	+65.5%	2,2 k €	+507%	356,1 €	-99.7%	105 k €	-15.2%	123,8 k €	+45.1%	85,3 k €	+294%	21,6 k €	+137%	9,1 k €	+11.1%	8,2 k €	-57.7%	19,5 k €	-83.9%	121 k €	-38.7%	197,4 k €	+194%	67,2 k €	-51.3%	137,8 k €	+48.7%	92,6 k €	-34.5%	141,5 k €
Debts	379 k €	-5.3%	400,4 k €	-4.4%	418,8 k €	-14.3%	488,4 k €	-22.0%	626,2 k €	+10.7%	565,5 k €	-16.1%	674,4 k €	+3.5%	651,4 k €	-3.8%	677 k €	-5.2%	714 k €	+3.3%	691 k €	-6.2%	736,5 k €	+0.2%	735,1 k €	+6.0%	693,4 k €	+103%	341,8 k €	+7.6%	317,6 k €	+7.8%	294,6 k €
Other
Workforce	0,0 ETP		0,0 ETP		0,0 ETP	-100%	1,0 ETP	0.0%	1,0 ETP	-16.7%	1,2 ETP	-20.0%	1,5 ETP	-25.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	+25.0%	1,6 ETP	-42.9%	2,8 ETP	-3.4%	2,9 ETP	+3.6%	2,8 ETP	0.0%	2,8 ETP	+3.7%	2,7 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 29 ended

Active mandates

Bart Waelput

Director · since 29 novembre 2023

Active

Ended mandates

Bart Waelput

Director · since 29 novembre 2023 · until 15 juin 2029

Ended

DRIEKONINGEN

Managing director · since 22 novembre 2021 · until 05 juin 2027 · 0438.821.169

Represented by Bart WAELPUT

Ended

PHARMA SOLUTIONS

Managing director · since 22 novembre 2021 · until 05 juin 2027 · 0468.526.628

Represented by Bart WAELPUT

Ended

Waelput Invest

Managing director · since 22 novembre 2021 · until 05 juin 2027 · 0875.668.884

Represented by Bart WAELPUT

Ended

At this address

Other companies at this address

Company	CBE no.
PHARMA SOLUTIONS● Active	0468.526.628
Waelput Invest● Active	0875.668.884

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/09/2025	11/10/2024	09/10/2023	21/12/2022	16/12/2021	10/12/2020
General meeting	26/09/2025	04/10/2024	04/10/2023	05/12/2022	22/11/2021	30/11/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	26/09/2025	29/09/2025	Dutch	PDF
Abridged model	31/12/2023	04/10/2024	11/10/2024	Dutch	PDF
Abridged model	31/12/2022	04/10/2023	09/10/2023	Dutch	PDF
Abridged model	31/12/2021	05/12/2022	21/12/2022	Dutch	PDF
Abridged model	31/12/2020	22/11/2021	16/12/2021	Dutch	PDF
Abridged model	31/12/2019	30/11/2020	10/12/2020	Dutch	PDF
Abridged model	31/12/2018	16/12/2019	30/12/2019	Dutch	PDF
Abridged model	31/12/2017	02/06/2018	26/06/2018	Dutch	PDF
Abridged model	31/12/2016	18/09/2017	22/09/2017	Dutch	PDF
Abridged model	31/12/2015	26/09/2016	28/09/2016	Dutch	PDF
Abridged model	31/12/2014	22/06/2015	15/07/2015	Dutch	PDF
Abridged model	31/12/2013	07/06/2014	25/06/2014	Dutch	PDF
Abridged model	31/12/2012	09/09/2013	26/09/2013	Dutch	PDF
Abridged model	31/12/2011	27/08/2012	27/09/2012	Dutch	PDF
Abridged model	31/12/2010	20/06/2011	27/06/2011	Dutch	PDF
Abridged model	31/12/2009	05/06/2010	26/08/2010	Dutch	PDF
Abridged model	31/12/2008	06/06/2009	17/07/2009	Dutch	PDF
Abridged model	31/12/2007	07/06/2008	19/06/2008	Dutch	PDF
Abridged model	31/12/2006	02/06/2007	09/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 29 ended

Active mandates

Bart Waelput

Director · since 29 novembre 2023

Active

Ended mandates

Bart Waelput

Director · since 29 novembre 2023 · until 15 juin 2029

Ended

DRIEKONINGEN

Managing director · since 22 novembre 2021 · until 05 juin 2027 · 0438.821.169

Represented by Bart WAELPUT

Ended

PHARMA SOLUTIONS

Managing director · since 22 novembre 2021 · until 05 juin 2027 · 0468.526.628

Represented by Bart WAELPUT

Ended

Waelput Invest

Managing director · since 22 novembre 2021 · until 05 juin 2027 · 0875.668.884

Represented by Bart WAELPUT

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates04/12/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
PDF
Registered office07/03/2022
MAATSCHAPPELIJKE ZETEL
PDF
Mandates03/02/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/01/2016
ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/09/2015
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/06/2012
ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/09/2009
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/05/2009
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 202426,8 k €↓
2023
Annual accounts 202341 k €↑
2022
Annual accounts 2022-19,5 k €↓
2021
Annual accounts 202140,2 k €↑
2018
Annual accounts 201818,6 k €↑
2017
Annual accounts 2017929,8 €↓
2016
Annual accounts 201615,5 k €↑
2015
Annual accounts 2015906,8 €↑
2014
Annual accounts 2014-6,6 k €↑
2013
Annual accounts 2013-30,2 k €↓
2012
Annual accounts 20128,7 k €↑
2011
Annual accounts 2011-7,6 k €↓
2010
Annual accounts 2010-943,7 €↑
2009
Annual accounts 2009-39,5 k €↓
2008
Annual accounts 200813,8 k €↑
2007
Annual accounts 2007-4,2 k €↓
2006
Annual accounts 200617,8 k €
27/06/1986
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

FARMA - BOVAN

Overview

What does FARMA - BOVAN do?

Trend over 17 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline